ENTO — Entero Therapeutics, Inc.

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $4.96 Analyst target: $36.00 Upside: 625.81%

See the full interactive analysis & chart →

Informational only — not investment advice.